R&D Women in life sciences: Why female representation still lags... pharmaphorum spoke with Sheila Diamond, director of scientific engagement at Medidata, about being a woman in STEM.
Patients The unmentionables: Challenging inequalities in women’s heal... As Women’s History Month continues, pharmaphorum web editor Nicole Raleigh welcomed a group of expert individuals onto the podcast to discuss not just the inequalities in women’s health, bu
News Merck rare tumour drug Ezmekly backed for NHS use Merck's drug for tumours associated with rare disease neurofibromatosis type 1, Ezmekly, has been cleared for NHS use in children as young as two.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
